ParenteralDosed ingredientTherapeutic flag Cosmetic cross-reference

Sodium Thiosulfate

CAS 7772-98-7

Sodium Thiosulfate (CAS 7772-98-7) is a Phase 4 pharmaceutical compound with 0 bioactivity targets and 50 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
50
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Sodium Thiosulfate
CAS Number
7772-98-7
UNII
HX1032V43M
InChIKey
PODWXQQNRWNDGD-UHFFFAOYSA-L
ChEMBL ID
CHEMBL2096650
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
dosed ingredientparenteraltherapeutic flag
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL2096650 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE DrugCentral 2 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Calciphylaxis 33 194.74 10051714
Off label use 67 75.193 10053762

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 4 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
Sodium Thiosulfate 36726 SU MTHSPL
SODIUM THIOSULFATE 36726 SU MTHSPL
sodium thiosulfate 36726 SU MTHSPL
sodium thiosulfate 36726 PIN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Sodium Thiosulfate used for in pharmaceutical contexts?

Sodium Thiosulfate (CAS 7772-98-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Sodium Thiosulfate?

Sodium Thiosulfate has 50 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Calciphylaxis, Off label use, Abdominal distension, Bilirubin urine present, Blood bilirubin increased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Sodium Thiosulfate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Sodium Thiosulfate with EU status "permitted".

What clinical phase is Sodium Thiosulfate in?

Sodium Thiosulfate is rendered with ChEMBL max phase 4 (approved).